chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood pressure dropped down to 85; Patient could not get out of bed; Slept on and off; Temperature of 100.4 °F; More than a shivering, like having convulsions; cold; Shaking; Left arm was a little bit tender; A spontaneous case was reported by a consumer concerning an 83-year-old female patient who experienced More than a shivering, like having convulsions, feeling cold/chilliness, shaking, Left arm was a little bit tender, blood pressure dropped down to 85, patient could not get out of bed, slept on and off) and temperature of 100.4 °F.   The patient's past medical history was not provided. Concomitant medications included blood thinners (unspecified).    On 26-Feb-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 26-Feb-2021, the patient experienced SEIZURE (More than a shivering, like having convulsions), NASOPHARYNGITIS (Cold), TREMOR (Shaking) and TENDERNESS (Left arm was a little bit tender). On an unknown date, the patient experienced BLOOD PRESSURE DECREASED (Blood pressure dropped down to 85), BEDRIDDEN (Patient could not get out of bed), SLEEP DISORDER (Slept on and off) and PYREXIA (Temperature of 100.4 °F). Treatment information was not provided for these events.   The action taken with mRNA-1273 in response to these events was unknown.  On 26-Feb-2021, SEIZURE (More than a shivering, like having convulsions), NASOPHARYNGITIS (Cold) and TREMOR (Shaking) outcome was unknown. On 28-Feb-2021, TENDERNESS (Left arm was a little bit tender) outcome was unknown. At the time of the report, BLOOD PRESSURE DECREASED (Blood pressure dropped down to 85), BEDRIDDEN (Patient could not get out of bed), SLEEP DISORDER (Slept on and off) and PYREXIA (Temperature of 100.4 °F) outcome was unknown.   The patient consented for safety follow-up.; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product and the start date of the reported event, and excluding any other etiology, a causal relationship with the event cannot be excluded
Information has been received from a licensed practical nurse (LPN) concerning a 12-month-old male, who on 11-Jun-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Approximately 2 weeks post vaccination, on about 25-Jun-2007, the patient had a "mild outbreak of varicella" that was considered to be not life threatening. The patient also had a cough and runny nose for which he was treated with some cough medicine and some oral diphenhydramine hydrochloride (BENADRYL). The only medical treatment he had was to visit the doctor. On an unspecified date, his symptoms subsided and he was considered recovered. This is one of several reports from the same reporter. Additional information has been requested.
Vaccine was expired on 09-Nov-2021 and was administered on 04-Jan-2022 past expiration, doses were stored in the freezer before administration; doses administered past expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past expiration) and PRODUCT STORAGE ERROR (Vaccine was expired on 09-Nov-2021 and was administered on 04-Jan-2022 past expiration, doses were stored in the freezer before administration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past expiration). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 09-Nov-2021 and was administered on 04-Jan-2022 past expiration, doses were stored in the freezer before administration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past expiration) and PRODUCT STORAGE ERROR (Vaccine was expired on 09-Nov-2021 and was administered on 04-Jan-2022 past expiration, doses were stored in the freezer before administration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  On 04-Jan-2022, patient received a dose (lot no: 048C21A) of Moderna vaccine (Expiry date: 09-Nov-2021)  No treatment drug details was reported.
A nurse reported the occurrence of injection site cellulitis in a 5-year-old subject of unspecified gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  The subject's medical history, concurrent conditions, and concurrent medications where unknown.  On 02/11/2003, the subject received an Infanrix injection (lot DTPA578A9).  Subsequently, the subject experienced injection site cellulitis; the diagnosis was made by the vaccine provider.  The reporting nurse did not know if the vaccine provider had examined the subject or prescribed any medication.  The reporting nurse stated that this event was possibly related to Infanrix administration.  As of 02/18/2003, the outcome of the event was unknown.  Comment:  This is one of five subjects, out of 19 children immunized, who developed injection site cellulitis following receipt of Infanrix lot DTPA578A9.  Please see reports A0397194A, A0398143A, A0398144A, and A0398145A.
Severe flu symptoms, diarrhea, shock, fainting--mild symptoms began about 6 hours after vaccination and became severe 10 hours after vaccination. Fainting resulted in facial bruising and smashed nose--bleeding.
Constant pain in the left arm at injection site near shoulder, numbness to wrist.  Unable to lift left hand and straighten hand only a few inches above head.  Unable to carry weight on left arm.  Started 2/5/21 until now, constant pain.  Used over the counter pain relievers, ice and heat packs.  Lidocaine and capsaicin creams with no relief
human globulin administered with second vaccination; Case reference number US-BN-2021-000265 is a spontaneous case report initially received from a patient via Agency (case reference number USBAV21-0123) on 18-Mar-2021, and concerns a male patient of an unknown demographic.  The patient's medical history was not provided.  The patient's concomitant medications included Human Globulin (immunoglobulin human normal).  On an unspecified date, also reported as five years ago, the patient received RabAvert (Inactivated Rabies Virus Vaccine, Batch no. was not provided) at an unknown dosage regimen, for an unknown indication.   On 16-Mar-2021, approximately five years after previously being vaccinated against Rabies, the patient was vaccinated for the second time and received the first dose of RabAvert (Inactivated Rabies Virus Vaccine, Batch no. was not provided) at unknown dosage regimen, for post-exposure treatment. The patient stated that human globulin (immunoglobulin) was administered along with the first dose of in the second course of Rabies vaccination (labelled drug-drug interaction issue), despite previously being immunized.  It was not reported if the patient experienced any adverse effect due to RabAvert.  No further information was provided.; Reporter's Comments: Labelled drug-drug interaction issue is listed per convention. Reportedly, the patient was vaccinated with RabAvert for the second time and human globulin was administrated along with the second vaccination, which is considered labelled drug-drug interaction issue. No adverse events were reported. Labelled drug-drug interaction issue is not related to Rabipur, but to human action. The case is considered non serious.; Sender's Comments: Labelled drug-drug interaction issue is listed per convention. Reportedly, the patient was vaccinated with RabAvert for the second time and human globulin was administrated along with the second vaccination, which is considered labelled drug-drug interaction issue. No adverse events were reported. Labelled drug-drug interaction issue is not related to Rabipur, but to human action. The case is considered non serious.
Order incident and administered what was thought to be Bivalent from the pharmacy but was Monovalent.   Patient had no reaction and was notified.
Right arm soreness; This is a spontaneous report from a contactable physician. A 32-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via intramuscular route, at the age of 32 years, administered in right arm on 23Dec2020 (Batch/Lot Number: EH9899) at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced right arm soreness. The event was considered as non-serious. The outcome of the event was unknown.
Ireturned home after i had the vaccine. around a half hour later I felt dizzy and sick to my stomach,  I began to vomit and vomit non stop. I wasn't able toget up on my own due to the dizziness, was not able to keep any thing down including fluids at this point my husband and I were not concerned as we were told there may be side effects normal withn the vaccine including vomiting and aches. This reaction {the vomiting and dizziness} continued for approximatly 24 to 36 hours. After the vomiting stopped, I still felt dizzy and weak and was unable to walk without holding on to things or i would falln down. I responded to all vsafe requests as well as husband, we both stated i was not doing well hping someone would contact either one of us. I figured rest would be the best for be to get back to myself, so thats what iI did,for approximately a week I slept feeling so weak and dizzy until the morning of 02/10/2021around 8:00 am i could hear my nephew doing his online schooling,  For some unknown reason this angered me, this was very unusual behavior for me I stumbled to the kitchen and started a confrontation with him and i ended up striking him at some point, the school had no choice but to call police and report my abuse . The police came to our home at appoximatly 2:00 pm They question nephew, my husband, my mother, and myself only to discover this was very unusual behavior from me and i had never done anything like that before.  My husband explained that I had been ill since I Recieved the covid vaccine, the vomiting, dizziness, inability to walk on my own irrational behavior, forgetfulness and the sleepiness.  The police called an ambulance, that transfered me to hospital, where they determined I had a brain bleed resultingf in a stroke.
pt recvd vax; 11nov & 12nov pt had fever of 105.5; MD said it could possibly have been from MMR;
Patient reports feeling tingling on top of her mouth, no other symptoms.  Patient was assessed by EMS, Cleared by EMS. BP; 130/80, pulse; 65, Spo2 99%
This case was reported by a pharmacist via call center representative and described the occurrence of injection site urticaria in a 83-year-old female patient who received SHINGRIX (batch number 9779K, expiry date 11th October 2020) for prophylaxis. On 9th July 2018 14:36, the patient received SHINGRIX (intramuscular) .5 ml. On 9th July 2018, several hours after receiving SHINGRIX, the patient experienced injection site urticaria, injection site warmth and injection site swelling. On an unknown date, the outcome of the injection site urticaria, injection site warmth and injection site swelling were unchanged. It was unknown if the reporter considered the injection site urticaria, injection site warmth and injection site swelling to be related to SHINGRIX. Additional details were received as follows: The vaccine was administered at 2:36 PM. The pharmacist reported that the patient received a dose of SHINGRIX and that evening experienced a raised, warm and welt at the injection site that was unchanged.
Right ankle swollen within an hour of injection.  Felt like sprain.  Still swollen but pain better today.  Took naproxen.
Post vax, the patient developed 57 x 50 mm erythema around the site and a 20 x 26 mm induration 48 hours after the injection.
Red, swollen arm approximately 2 days after admin seen by MD, diagnosed w/ cellulitis & treated w/ Clindamycin 300mg 1 PO TID.
Patient went through ER on 4/27/06. Diagnosed with seizure disorder and transferred to hospital. 5/15/06Received medical records from hospital which revealed patient admitted 4/27 w/dx new onset seizures.  PMH: normal SVD w/o complication, only bronchitis.  Patient's mother had seizure disorder & found to have brain tumor.  Ped neuro cx. D/C home 5/2/06/ss
Patient is 33-year-old male s/p Anthrax vaccination on the 10th of February who presents with a large local reaction.  He complains of swelling that occurred within 12 hours of the injection.  He feels that since that time the swelling has been pretty persistent with no significant increase in the amount of swelling but has not resolved either.  He also complained of headaches and weakness that was noted about 6 hours after the vaccination.  He took 400 mg of motrin with improvement of his symptoms.  He denies any vomiting but felt some nausea at the time.  No fevers or chills.  No joint aches.  By the next morning the weakness and dizziness was gone but the swelling was noticed.  The swelling is a little itchy but not generally painful.  No weakness in hands or arms.
Congestive heart failure 3 months post vax. Aortic valve failure and replaced via open heart on Dec.28,2021.
Painful Rash followed by Shingles diagnosis.  7 days headache, body aches, mostly bedridden.
DAVELOPED HEADACHE, BODY ACHES, FEVER, BACK ACHE, EXTREME CHILLS, NIGHT SWEATS, EXTREME FATIGUE
On the morning of Saturday, 7/14/07, two days after the DECAVAC vaccination, I felt abnormal lethargy and fatigue, accompanied by generalized aching of muscles and joints. These conditions persisted through the weekend, to the point that I was unable to do my normal exercise routines of upper body weight training, yoga, and one-hour hikes. On Monday, 7/16/07, I attempted my normal one-hour exercise routine of hiking at 5:30 PM, and I had a turn back from the trail after 30 minutes. I was physically unable to ascend a small hill I have hiked up literally hundreds of times. My muscles lacked strength, and I lacked energy. On Tuesday, 7/17/07, the continued severe fatigue and body aches alarmed me to the point that I called Urgent Care to ask if I was experiencing an adverse or allergic response to the vaccination. The response from the nurse at Urgent Care, who consulted with the physician, was affirmative...that I must be suffering an allergic reaction, for which there is nothing to do. I would add that there are two recent base-line measures of my physical condition prior to the DECAVAC vaccination. On June 6, 2007, I had a complete physical examination, including blood work and EKG, at the office of Dr. at the medical center.  The results show I am in fine shape. On the morning of July 4, 2007, I ascended to the summit of the peak, at 12,600 feet in the San Francisco Peaks, in 2 hours 42 minutes. This is a 4.8 mile hike (one-way), with an altitude gain of over 3000 feet. The physical exam, and my ability to hike rapidly at higher altitude, provide a standard by which to gauge the rapid deterioration of my health and my capabilities two days after the DECAVAC vaccination.
Itching in throat and on tongue, numbness of tongue, tingling around lips, sudden feeling of clammy coldness.  Given a Benadryl pill by a nurse and blood pressure taken.  Waited roughly an hour.
chills, weak, dry mouth @ 11AM;sent to ER - chest pains, palpitations @ ER;tx see allergy in #19 below;
Several hours after injection  I began experiencing severe and extreme muscle and joint pain in head, neck, and left shoulder and arm.  Further into the evening and past midnight I started experiencing shortness of breath and extreme headache pain above the eyes. Extremely Sharp pain in the right arm and shoulder, felt like my arm was being aggressively yanked.  I then became panicky and decided to call a 24 Hour nurse service and describe what I was experiencing.  After spending 20 minute on the phone with the nurse she concluded that an emergency room visit was necessary but that I should contact my doctor at the beginning of the next business day.  The pain still exists.
The rash comes and goes; my lips had swelled; random red itchy spots all over body to include face, forearms, top of hands,legs and chest; welts all over body to include face, forearms, top of hands,; getting hives daily; This is a spontaneous report from a contactable other healthcare professional. A 32 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 18Feb2021 (Batch/Lot Number: EN6201) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced the rash that comes and goes, her lips had swelled, random red itchy spots all over body to include face, forearms, top of hands,legs and chest causing pruritus, welts all over body to include face, forearms, top of hands causing urticaria on 26Feb2021 with outcome of recovering.   No follow up attempts are needed; no further information is expected
Numbness and warm tingling sensation in upper arm. Persisted for several hours. Began almost immediately after injection and travelled from injection site to near the elbow. Slowly dissipated after serval hours.
patient received the Moderna covid-19 vaccine and two days later states she was admitted to the ER with blood clots. patient did not report the even to the pharmacy until the week of June 1st
Weakness; Elevated BP; Elevated glucose readings; This is a spontaneous report from a contactable other healthcare professional. A 82-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via intramuscular route of administration on 21Mar2021 (at the age of 82-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, hypertension, hyperlipidemia, osteoporosis, seasonal allergies, COVID-19 and anxiety. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had received an unspecified concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 22Mar2021, since taking her second dose of vaccination, the patient had weakness, elevated blood pressure (BP) and elevated glucose readings (200's). On 22Mar2021, the patient underwent blood pressure test and the result was found to be elevated and on the same date, the patient also underwent blood glucose levels test and the result was found to be elevated glucose readings (200's). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness, elevated BP and elevated glucose readings (200's) was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. On 29-AUG-2014 the patient was vaccinated with PNEUMOVAX 23 lot # J006242, intramuscular, once in the left deltoid. The consumer's medical history, concomitant medications, and past drug history are unknown. It was later noticed that this vaccine had expired on 03-AUG-2014. At the time of the call the pharmacist reported that the patient had not called to report any adverse events. There was no laboratory data reported. As of 29-AUG-2014 it is unknown if the patient will receive another injection of PNEUMOVAX 23 and the outcome of receiving expired vaccine is unknown. Additional information has been requested.
10.9.07 3:30 Patient: reports developed blotches on face and itchy sensation from neck to forehead with same puffiness. Relief with baking soda and warm water. Received Flu vaccine on 10-8-07 and developed symptoms about 6 hours later. Reports not as itchy today but blotchy looking plan: notify HCP. 930 10/10/07 patient reports face puffy, dry, itchy, and blotchy: To call HCP.
Periods of sweating and chills, body aches and elevated heart rate for about 24 hours
Ten hours after the shot I experienced chills for over 2 hours, followed up with fever, headache, nausea, extremely tired, no appetite.  Felt pretty much back to normal the second day after the shot.
I got my first dose of the Moderna vaccine on 2/24/2021. About a week later, I woke up one morning with my right arm burning at the injection site. I then got out of bed and saw that there was a rash there. It was a burning rash that had some itching; it almost felt like shingles. I saw a doctor at Medical Offices, and he though it was what is commonly called "COVID arm." He gave me a steroid cream to put on it, and it went away in 2-3 days. I got my second dose on 3/24/2021. Immediately after the shot, there was a welt at the injection site. They had me wait for 30 minutes afterwards at the pharmacy to make sure I didn't have an anaphylactic reaction. They checked my arm before I left to see if the swelling had gone down, which it had. I had no more problems afterwards.
Date place in refrigerator-12-Nov-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Date place in refrigerator-12-Nov-2021) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date place in refrigerator-12-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Date place in refrigerator-12-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  The vial was placed in refrigerator on 12-Nov-2021. It was reported that the expired lots were administered due to the confusion with expiry date printed in the carton and the expiration date when the QR code was scanned. The vials did not undergo temperature excursion. The patient did not experience any adverse event.  No treatment information were provided.